Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment.
Publication
, Journal Article
Tcheng, JE
Published in: Am J Cardiol
May 6, 1999
Duke Scholars
Published In
Am J Cardiol
DOI
ISSN
0002-9149
Publication Date
May 6, 1999
Volume
83
Issue
9A
Start / End Page
7E / 11E
Location
United States
Related Subject Headings
- Tyrosine
- Tirofiban
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Platelet Aggregation
- Peptides
- Immunoglobulin Fab Fragments
- Humans
- Eptifibatide
- Coronary Disease
Citation
APA
Chicago
ICMJE
MLA
NLM
Tcheng, J. E. (1999). Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment. Am J Cardiol, 83(9A), 7E-11E. https://doi.org/10.1016/s0002-9149(99)00084-3
Tcheng, J. E. “Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment.” Am J Cardiol 83, no. 9A (May 6, 1999): 7E-11E. https://doi.org/10.1016/s0002-9149(99)00084-3.
Tcheng JE. Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment. Am J Cardiol. 1999 May 6;83(9A):7E-11E.
Tcheng, J. E. “Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment.” Am J Cardiol, vol. 83, no. 9A, May 1999, pp. 7E-11E. Pubmed, doi:10.1016/s0002-9149(99)00084-3.
Tcheng JE. Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment. Am J Cardiol. 1999 May 6;83(9A):7E-11E.
Published In
Am J Cardiol
DOI
ISSN
0002-9149
Publication Date
May 6, 1999
Volume
83
Issue
9A
Start / End Page
7E / 11E
Location
United States
Related Subject Headings
- Tyrosine
- Tirofiban
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Platelet Aggregation
- Peptides
- Immunoglobulin Fab Fragments
- Humans
- Eptifibatide
- Coronary Disease